Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total Stockholders' Equity	Non-controlling Interest-Operating Partnership
Balance at Dec. 31, 2020	$ 1,413,442	$ 1,196	$ 1,835,494	$ (446,519)	$ 1,390,171	$ 23,271
Balance (in shares) at Dec. 31, 2020		119,638,000
Net income (loss)	(51,896)			(51,896)	(51,896)
Retirement of common stock	(1,639)	$ (2)	(1,637)		(1,639)
Retirement of common stock (in shares)		(220,000)
Dividends on RSUs	(275)			(275)	(275)
Restricted stock compensation, net of forfeitures	18,733		18,733		18,733
Restricted stock grants		$ 9	(9)
Restricted stock grants (in shares)		867,000
Distributions to non-controlling interest	(5,897)					(5,897)
Termination of operating partnership			17,374		17,374	$ (17,374)
Balance at Dec. 31, 2021	1,372,468	$ 1,203	1,869,955	(498,690)	1,372,468
Balance (in shares) at Dec. 31, 2021		120,285,000
Net income (loss)	122,320			122,320	122,320
Retirement of common stock	(79,887)	$ (71)	(79,816)		(79,887)
Retirement of common stock (in shares)		(7,141,000)
Dividends on RSUs	(61)			(61)	(61)
Restricted stock compensation, net of forfeitures	17,568		17,568		17,568
Restricted stock grants		$ 18	(18)
Restricted stock grants (in shares)		1,844,000
Balance at Dec. 31, 2022	1,432,408	$ 1,150	1,807,689	(376,431)	1,432,408
Balance (in shares) at Dec. 31, 2022		114,988,000
Net income (loss)	67,590			67,590	67,590
Retirement of common stock	(43,186)	$ (40)	(43,146)		(43,186)
Retirement of common stock (in shares)		(3,936,000)
Dividends declared on common stock	(6)			(6)	(6)
Restricted stock compensation, net of forfeitures	20,760		20,760		20,760
Restricted stock grants		$ 17	(17)
Restricted stock grants (in shares)		1,681,000
Balance at Dec. 31, 2023	$ 1,477,566	$ 1,127	$ 1,785,286	$ (308,847)	$ 1,477,566
Balance (in shares) at Dec. 31, 2023		112,733,000